LFCR - Lifecore Biomedical, Inc. Stock Analysis | Stock Taper
Logo

About Lifecore Biomedical, Inc.

https://www.lifecore.com

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments.

Paul Josephs

CEO

Paul Josephs

Compensation Summary
(Year 2024)

Salary $505,582
Stock Awards $1,856,250
Incentive Plan Pay $38,494
All Other Compensation $91,087
Total Compensation $2,491,413
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Went public February 15, 1996
Method of going public IPO
Full time employees 524

ETFs Holding This Stock

Ratings Snapshot

Rating : D+

Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1

Price Target

Target High $8
Target Low $5
Target Median $6.5
Target Consensus $6.5